Memorial Sloan Kettering Cancer Center Onc. Dept.. is a clinical research site located in New York, New York, United States 10021.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Memorial Sloan Kettering Cancer Center Onc. Dept.. has participated in 1 clinical trials.
Therapeutic areas: Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3, Squamous Lung Cancer With FGFR1 Amplification, Bladder Cancer With FGFR3 Mutation or Fusion.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Memorial Sloan Kettering Cancer Center Onc. Dept.. has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Memorial Sloan Kettering Cancer Center Onc. Dept.. has 1 clinical trials on record. Their work covers Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3, Squamous Lung Cancer With FGFR1 Amplification, Bladder Cancer With FGFR3 Mutation or Fusion.
Memorial Sloan Kettering Cancer Center Onc. Dept.. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.